博苑股份2月9日获融资买入1179.68万元,融资余额1.81亿元

Group 1 - On February 9, Boyuan Co., Ltd. saw a stock increase of 1.82% with a trading volume of 133 million yuan, while the margin trading data indicated a net margin buy of -1.39 million yuan for the day [1] - As of February 9, the total margin trading balance for Boyuan Co., Ltd. was 181 million yuan, which accounted for 4.42% of its circulating market value, indicating a high level compared to the 90th percentile over the past year [1] - The company had no short selling activity on February 9, with a short selling balance of 0 shares, also reflecting a high level compared to the 90th percentile over the past year [1] Group 2 - Boyuan Co., Ltd. was established on August 6, 2008, and is located in Shouguang City, Shandong Province, focusing on the research, production, and sales of fine chemicals, including organic and inorganic iodides, precious metal catalysts, and luminescent materials [2] - The company's main business revenue composition includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2] - For the period from January to September 2025, Boyuan Co., Ltd. achieved an operating income of 1.073 billion yuan, representing a year-on-year growth of 6.60%, while the net profit attributable to shareholders decreased by 22.53% to 132 million yuan [2] Group 3 - Since its A-share listing, Boyuan Co., Ltd. has distributed a total of 88.41 million yuan in dividends [3] - As of September 30, 2025, the top ten circulating shareholders included several new institutional investors, with notable holdings such as 1.3456 million shares by Zhonghang New Start Flexible Allocation Mixed A [3]

Shandong Boyuan Pharmaceutical &Chemical Co.,Ltd-博苑股份2月9日获融资买入1179.68万元,融资余额1.81亿元 - Reportify